Bristol-Myers Squibb (BMY) Misses Q2 EPS by 23c, Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $59.12 -0.77%
Revenue Growth %: +3.4%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
HOVR, VFS, PGR, More
Revenue Growth %: +3.4%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.75, $0.23 worse than the analyst estimate of $1.98. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $11.81 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2023 EPS of $7.35-$7.65, versus the consensus of $7.99.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure
- Bristol-Myers Squibb Co. (BMY) PT Raised to $41 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
